Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Steven E. Nissen(Cleveland Clinic), A. Michael Lincoff(Cleveland Clinic)
Cited by 846
Related Papers
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
|New England Journal of Medicine|2007|4.7k
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
|New England Journal of Medicine|2023|2.6k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
|Circulation|2018|712